Li Y, Zhang L, Zheng G, Li J, Ma Z, Jia X
Medicine (Baltimore). 2024; 103(27):e38796.
PMID: 38968455
PMC: 11224870.
DOI: 10.1097/MD.0000000000038796.
Nishio J, Nakayama S, Aoki M
Int J Mol Sci. 2024; 25(2).
PMID: 38256198
PMC: 10816835.
DOI: 10.3390/ijms25021127.
Suster D, Michal M, Huang H, Ronen S, Springborn S, Debiec-Rychter M
Mod Pathol. 2020; 33(12):2520-2533.
PMID: 32514165
DOI: 10.1038/s41379-020-0580-6.
Rougemont A, Berczy M, Marq N, McKee T, Christinat Y
Virchows Arch. 2019; 475(2):251-254.
PMID: 30911815
DOI: 10.1007/s00428-019-02556-2.
Srivastava P, Husain N, Neyaz A, Gupta V
BMJ Case Rep. 2018; 2018.
PMID: 30021730
PMC: 6058101.
DOI: 10.1136/bcr-2018-224259.
Acral myxoinflammatory fibroblastic sarcoma with hybrid features of hemosiderotic fibrolipomatous tumor occurring 10 years after renal transplantation.
Hallin M, Miki Y, Hayes A, Jones R, Fisher C, Thway K
Rare Tumors. 2018; 10:2036361318782626.
PMID: 29977483
PMC: 6024276.
DOI: 10.1177/2036361318782626.
Recurrent BRAF Gene Rearrangements in Myxoinflammatory Fibroblastic Sarcomas, but Not Hemosiderotic Fibrolipomatous Tumors.
Kao Y, Ranucci V, Zhang L, Sung Y, Athanasian E, Swanson D
Am J Surg Pathol. 2017; 41(11):1456-1465.
PMID: 28692601
PMC: 5636656.
DOI: 10.1097/PAS.0000000000000899.
Myxoinflammatory Fibroblastic Sarcoma: A Radiographical, Pathological, and Immunohistochemical Report of Rare Malignancy.
Kato M, Tanaka T, Ohno T
Case Rep Orthop. 2015; 2015:620923.
PMID: 26090253
PMC: 4451774.
DOI: 10.1155/2015/620923.
Giant myxoinflammatory fibroblastic sarcoma with bone invasion: a very rare clinical entity and literature review.
Togral G, Arikan M, Aktas E, Gungor S
Chin J Cancer. 2014; 33(8):406-10.
PMID: 25011461
PMC: 4135371.
DOI: 10.5732/cjc.014.10049.
Acral myxoinflammatory fibroblastic sarcoma: A case report and literature review.
Silver A, Baynosa R, Mahabir R, Wang W, Zamboni W, Khiabani K
Can J Plast Surg. 2014; 21(2):92-4.
PMID: 24431949
PMC: 3891089.
DOI: 10.1177/229255031302100201.
A case of lung metastasis in myxoinflammatory fibroblastic sarcoma: analytical review of one hundred and thirty eight cases.
Lombardi R, Jovine E, Zanini N, Salone M, Gambarotti M, Righi A
Int Orthop. 2013; 37(12):2429-36.
PMID: 24158237
PMC: 3843193.
DOI: 10.1007/s00264-013-2048-5.
Myxoinflammatory fibroblastic sarcoma: a clinicopathologic analysis of 104 cases, with emphasis on predictors of outcome.
Laskin W, Fetsch J, Miettinen M
Am J Surg Pathol. 2013; 38(1):1-12.
PMID: 24121178
PMC: 7670880.
DOI: 10.1097/PAS.0b013e31829f3d85.
Updates on the cytogenetics and molecular cytogenetics of benign and intermediate soft tissue tumors.
Nishio J
Oncol Lett. 2012; 5(1):12-18.
PMID: 23255885
PMC: 3525488.
DOI: 10.3892/ol.2012.1002.
Cytogenetics and molecular genetics of myxoid soft-tissue sarcomas.
Nishio J, Iwasaki H, Nabeshima K, Naito M
Genet Res Int. 2012; 2011:497148.
PMID: 22567356
PMC: 3335514.
DOI: 10.4061/2011/497148.
Consistent t(1;10) with rearrangements of TGFBR3 and MGEA5 in both myxoinflammatory fibroblastic sarcoma and hemosiderotic fibrolipomatous tumor.
Antonescu C, Zhang L, Nielsen G, Rosenberg A, Dal Cin P, Fletcher C
Genes Chromosomes Cancer. 2011; 50(10):757-64.
PMID: 21717526
PMC: 3361892.
DOI: 10.1002/gcc.20897.
Soft tissue sarcomas with complex genomic profiles.
Guillou L, Aurias A
Virchows Arch. 2010; 456(2):201-17.
PMID: 20217954
DOI: 10.1007/s00428-009-0853-4.
A rare case of acral myxoinflammatory fibroblastic sarcoma at the hand.
Acciaro A, Gabrieli R, Landi A
Musculoskelet Surg. 2010; 94(1):53-7.
PMID: 20066525
DOI: 10.1007/s12306-009-0053-z.
Myxoinflammatory fibroblastic sarcoma: investigations by comparative genomic hybridization of two cases and review of the literature.
Baumhoer D, Glatz K, Schulten H, Fuzesi L, Fricker R, Kettelhack C
Virchows Arch. 2007; 451(5):923-8.
PMID: 17694321
DOI: 10.1007/s00428-007-0480-x.